Management of Acute Atrophic Erythematous Candidiasis in a Diabetes Mellitus Patient: A Case Report

Authors

  • Irene Anastasia Tampubolon Resident of Oral Medicine Specialist Study Program, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
  • Nurina Febriyanti Ayuningtyas Lecturer of Department of Oral Medicine, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
  • Aulya Setyo Pratiwi Lecturer of Department of Oral Medicine, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
  • Gremita Kusuma Dewi Resident of Oral Medicine Specialist Study Program, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
  • Reiska Kumala Bakti Universitas Airlangga
  • Ardyta Lintang Maheswari Student of Dental Profession Program, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia

DOI:

https://doi.org/10.46862/interdental.v22i1.13091

Keywords:

Acute Atrophic Erythematous Candidiasis, diabetes mellitus, non-albicans Candida, nystatin

Abstract

Introduction: Acute atrophic erythematous candidiasis is an oral mucosal infection caused by overgrowth of Candida spp., commonly associated with immunocompromised conditions such as diabetes mellitus. It presents as painful, erythematous lesions that may impair quality of life if untreated.

Case: A 47-year-old male presented with tongue pain. Intraoral examination showed a well-demarcated, elongated erythematous lesion on the anterior one-third of the left dorsal tongue, measuring 2.5 × 1 cm, with a smooth surface and tenderness on palpation. The patient had uncontrolled diabetes mellitus (HbA1c 10.6%) and was on metformin, glimepiride, and amlodipine.

Case Management: Fungal culture confirmed Candida glabrata and Candida tropicalis. The patient received topical nystatin oral suspension four times daily for two weeks. After 22 days, complete healing was observed. Poor glycemic control likely increased susceptibility through impaired immunity and changes in the oral environment. The presence of non-albicans Candida species reflects infection patterns in immunocompromised patients.

Conclusion: Oral candidiasis is closely associated with diabetes mellitus. Effective management requires antifungal therapy combined with glycemic control and improved oral hygiene.

Downloads

Download data is not yet available.

References

1. Glick M, Greenberg MS, Lockhart PB, Challacombe SJ. Burket’s Oral Medicine (13th ed.). Edited by M. Glick. Philadelphia, PA: Wiley-Blackwell; 2021. p.1136. ISBN: 978-1-119-59781-70.

2. Archilla AR, Rosales CP. Candida species oral detection and infection in patients with diabetes mellitus: a meta-analysis. Iberoam J Med. 2021; 3(2): 115-121. Doi: 10.5281/zenodo.4495286 .

3. Kurniawan AA, Wardana T, Darmawan AR. Laporan kasus: kandidiasis akut eritematous pada penderita diabetes melitus. Stomatognatic - Jurnal Kedokteran Gigi 2018; 15(1): 21. Doi: 10.19184/stoma.v15i1.17909

4. Koesoemawati R. Differences in the number of candida albicans colonies on acrylic resin and thermo-plastic nylon in soursop leaf extract immersion. Interdental: Jurnal Kedokteran Gigi 2021; 17(2): 123-131. Doi: 10.46862/interdental.v17i2.2931

5. Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. Infections in Patients with Diabetes Mellitus. Journal of Clinical Medicine 2019; 8(1): 76. Doi: 10.3390/jcm801007

6. Ganesha R, Setyaningtyas D, Savitri DE, Hadi P, Israyani. Tatalaksana recurrent intra oral herpes disertai candidiasis yang dirujuk oleh dermatologist. Interdental Jurnal Kedokteran Gigi 2020; 16(1): 19–23. Doi: 10.46862/interdental.v16i1.794

7. Kim JH, Ahn JM. Clinical characteristics of patients with oral Candidiasis. J Oral Med Pain. 2021; 46(2): 33–40. Doi: 10.14476/jomp.2021.46.2.33

8. Farah C, Balasubramaniam R, McCullough MJ. Contemporary oral medicine: A comprehensive approach to clinical practice. Cham, Switzerland: Springer; 2019. Doi: 10.1007/978-3-319-72303-7.

9. Mohammadi F, Javaheri MR, Nekoeian S, Dehghan P. Identification of Candida species in the oral cavity of diabetic patients. Current medical mycology 2016; 2(2): 1–7. Doi: 10.18869/acadpub.cmm.2.2.4

10. Cervino G, Terranova A, Briguglio F, De Stefano R, Famà F, D'Amico C, Amoroso G, Marino S, Gorassini F, Mastroieni R, Scoglio C, Catalano F, Lauritano F, Matarese M, Lo Giudice R, Nastro Siniscalchi E, Fiorillo L. Diabetes: Oral Health Related Quality of Life and Oral Alterations. BioMed research international 2019; 5907195. Doi: 10.1155/2019/5907195

11. Chevalier M, Ranque S, Prêcheur I. Oral fungal-bacterial biofilm models in vitro: a review. Medical mycology 2018; 56(6): 653–667. Doi: 10.1093/mmy/myx111

12. Swidergall M, Filler SG. Oropharyngeal Candidiasis: Fungal Invasion and Epithelial Cell Responses. PLoS Pathog 2017; 13(1): e1006056. Doi:10.1371/journal.ppat.1006056

13. Nakagawa Y. Influence of dry mouth and denture use as predisposing factors for erythematous candidiasis. Annals of Japan Prosthodontic Society 2018; 10(1): 32–39. Doi: 10.2186/ajps.10.32.

14. Sampath A, Weerasekera M, Gunasekara C, Dilhari A, Bulugahapitiya U, Fernando N. A sensitive and a rapid multiplex polymerase chain reaction for the identification of Candida species in concentrated oral rinse specimens in patients with diabetes. Acta odontologica Scandinavica 2017; 75(2): 113–122. Doi: 10.1080/00016357.2016.1265146

15. Parmasari WD, Masfufatun, Juliati T. Incidence Of Oral Candidiasis In Fixed Orthodontic Appliances. Interdental Jurnal Kedokteran Gigi 2024; 20(1): 103-7. Doi: 10.46862/interdental.v20i1.8505

16. Prabhu SR. Handbook of Oral Pathology and Oral Medicine. Hoboken, New Jersey, United States: Wiley-Blackwell; 2021. p.496. ISBN: 978-1-119-78117-7

17. Acitores LRM, Azcárate FHR, Casañas E, Serrano J, Hernández G, Pintor RL. Xerostomia and salivary flow in patients taking antihypertensive drugs. International journal of environmental research and public health 2020; 17(7): 2478. Doi: 10.3390/ijerph17072478.

18. Huang S, Zeng X, Deng S, He S, Liu F. Prevalence of xerostomia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. BMC oral health 2025; 25(1): 662. Doi: 10.1186/s12903-025-05992-6

19. Aprista S, Nelis S, Nasia AA, Prabowo YB. The effect of xerostomia on the quality of life of controlled and uncontrolled type 2 diabetes mellitus patients. Padjadjaran Journal of Dentistry 2023; 35(1): 5–9. Doi: 10.24198/pjd.vol35.

20. Végh D, Bencze B, Banyai D, Vegh A, Rózsa N, Dobó CN, Biczo Z, Kammerhofer G, Ujpal M, Agurto LD, Pedrinaci I, Cardelles JPF, Magrin GL, Padhye NM, Mente L, Payer M, Hermann P. Preoperative HbA1c and Blood Glucose Measurements in Diabetes Mellitus before Oral Surgery and Implantology Treatments. International journal of environmental research and public health 2023; 20(6): 4745. Doi: 10.3390/ijerph20064745 .

Downloads

Published

2026-04-30

How to Cite

1.
Tampubolon IA, Ayuningtyas NF, Pratiwi AS, Dewi GK, Bakti RK, Maheswari AL. Management of Acute Atrophic Erythematous Candidiasis in a Diabetes Mellitus Patient: A Case Report. interdental [Internet]. 2026 Apr. 30 [cited 2026 May 1];22(1):173-80. Available from: https://e-journal.unmas.ac.id/index.php/interdental/article/view/13091